Prevalence of cannabis use disorders and associated factors among privately insured adults with epilepsy
PWE with substance use and psychiatric disorders are more likely to have CUD. Given the widespread prevalence of marijuana legalization across the U.S., increased awareness and potential screening for substance use disorders needs to be considered in epilepsy clinics.
Authors
- Robert C. Addy (ORCID: https://orcid.org/0000-0002-8690-497X)
- Refugio Sepulveda
- Sahiti Myneni (ORCID: https://orcid.org/0000-0002-9211-1626)
- Ross Shegog (ORCID: https://orcid.org/0000-0003-2750-0817)
- Youngran Kim (ORCID: https://orcid.org/0000-0002-2063-5017)
- Katarzyna Czerniak (ORCID: https://orcid.org/0000-0003-0106-0067)
Institutions
- University of Arizona (US)
- Institute of Informatics of the Slovak Academy of Sciences (SK)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fneur.2025.1695511
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00